Measuring physical activity "If a measurement matters at all, it is because it must have some conceivable effect on decisions and behaviour. If we can't identify a decision that could be affected by a proposed measurement and how it could change those decisions, then the measurement simply has no value." 20 PA can be measured either directly (using video techniques) or indirectly (with questionnaires and diaries, doubly labeled water techniques, and activity sensors). These methods are summarized in a 2006 review by Pitta et al. 21 Direct observation Quantification of PA through direct observation is typically performed in real time by observers or by review of video output. Because it is time-consuming, it cannot be practically used if the required sample size for the study is too large.
Doubly labeled water Doubly labeled water testing provides an indirect assessment of total energy expenditure, not PA per se. 22 For this testing, deuterium and 18 O are ingested; the deuterium washes out of the body via renal excretion, while the 18 O washes out as water and carbon dioxide. The difference in washout can be used to estimate global carbon dioxide production, which can then be converted into an estimate of energy expenditure. This technique estimates energy expenditure over long periods of free living conditions, which has obvious advantages and disadvantages. It does not permit the separation of PA-associated energy expenditure from the basal metabolic rate or diet-induced energy expenditure. Also, because of its "broad strokes" assessment, it cannot assess temporal patterns or bouts. The technique is perhaps more suited to obesity research, where global energy expenditure is more relevant.
Questionnaires and activity diaries Activity assessment via questionnaires and activity diaries are forms of subjective, patient-reported outcomes that involve self-reporting of activities. Being inexpensive and (usually) easy to complete, they are most useful for large clinical or epidemiologic studies. As is generally the case, validated questionnaires and diaries should be used for estimation of activity. Diary information is usually entered daily or several times daily; questionnaires are usually completed much less frequently. Self-reporting has the advantage of incorporating the patient's perspective and relevance; however, it has potential disadvantages, including perceptual deficiencies and recall errors due to patient-related factors (including age, cultural background, occupational status, and cognitive ability) as well as reliance on the design and psychometric properties of the instrument.
Activity monitors Activity monitors designed for measuring PA are, in essence, motion sensors. These include pedometers, which estimate COPD. 9 Our paper will summarize important aspects of this document, including: 1) definition and concept of PA; 2) objective measurement of activity; 3) prevalence of inactivity; 4) clinical relevance of activity disorder; and 5) potential interventions that might improve activity in COPD patients.
Definitions and concepts: physical activity and exercise The concepts "physical activity" and "exercise", although overlapping, are distinct. PA can be defined as "any bodily movement produced by skeletal muscles that results in energy expenditure." 10 Using similar reasoning, physical inactivity is defined as "an absence of physical activity or exercise." 11 PA is strongly influenced by individual attitudes and social, cultural, seasonal, and environmental factors. 9 PA can be characterized in several ways, including type, context, intensity, duration, bouts, and patterns.
12 Basic activities of daily living are those activities that involve everyday tasks centering on self-care and independent living 13,14 ; this subset traditionally has its own assessment methods. [15] [16] [17] [18] [19] Since the complete absence of PA in living persons is unusual, physical inactivity is often operationally defined using threshold activity values. One such classification places healthy individuals in an inactive category by not meeting any of the following 3 criteria: 1) 30 minutes of moderate-intensity PA on at least 5 days every week; 2) 20 minutes of vigorous-intensity PA on at least 3 days every week; 3) an equivalent combination achieving 600 MET-minutes per week.
2 While these criteria are appropriate for healthy adults and adolescents, they are too stringent for most patients with symptomatic COPD. In other words, most COPD patients with moderate or severe disease (by spirometry) would fall into the inactive category, making this categorization less useful for predicting outcome within this group.
Physical exercise is not synonymous with PA. Rather, exercise is a subset of PA, in which generally higher levels of muscular activity are performed for a purpose, such as achieving physical fitness or winning a sporting contest.
10,14 Similarly, exercise capacity and PA level, although interrelated, are different constructs: higher exercise capacity, often attained after prolonged exercise training, is permissive of greater PA (intensity and duration) in the home and community settings. However, achieving a greater level of exercise capacity does not necessarily mean that higher PA will follow, since the latter is modified by other factors such as motivation, leisure time, occupation, etc. There is, therefore, a sizeable gap between what individuals can do in the laboratory setting and what they actually do once they leave this environment. This has obvious implications if the PA level is predictive of an outcome, independent of exercise capacity: successful efforts at increasing exercise capacity may not automatically lead to increases in PA.
Physical inactivity and patient-related outcomes in chronic obstructive pulmonary disease Physical inactivity in patients with COPD is associated with several clinically-important adverse outcomes. It should be noted, however, that the often-strong associations described below do not necessarily imply a causal link. 30 For example, the presence of a particular chronic disease may increase mortality risk and may independently reduce functional status. In this situation, reduced functional status may simply be an epiphenomenon, and not directly related to the risk of death. However, the link between inactivity in COPD, and in healthy subjects as well, to poor outcomes is so pervasive that a strong case can be made for causal inference.
Exercise performance Sustained physical inactivity over years appears to be associated with accelerated reductions in exercise tolerance and decreased fat-free mass, the latter being a marker for muscle depletion. 31
Mortality
The association between physical inactivity and increased all-cause mortality has been demonstrated in prospective analyses. In 2006, Garcia-Rio et al 32 showed a relationship between objectively-measured PA and mortality in 173 patients with COPD. Their activity assessment came from a triaxial accelerometer worn on the waist over 5 consecutive days, recording 1-minute epochs of movement as vector magnitude units (movements in 3 planes summed over each minute). After an initial activity assessment, patients were followed up for 5 to 8 years. Even when the investigators entered potential confounders in their multivariate statistical modeling, lower activity remained a significant predictor of increased all-cause mortality, along with comorbidity and exercise endurance time.
In what would become a landmark study, Garcia-Aymerich et al 33 in 2006 reported on their study relating physical inactivity to health care utilization and mortality. They studied data from over 2000 individuals who had participated in the Copenhagen City Heart Study and had demonstrated airway obstruction, relating questionnaire-derived PA information to subsequent outcome. 33 For this analysis, they divided baseline, self-reported activity into 4 categories: very low, low, moderate, and high. Very-low, low, moderate, and high levels of PA were present at baseline in 9%, 12%, 46%, and 33% of participants, respectively. The dates and causes of subsequent hospital admissions and mortality were then obtained from Danish registries. After adjustment for relevant confounders (such as age, sex, severity of airflow obstruction, or the presence of ischemic heart disease), those individuals above the verylow PA category had a lower risk of all--cause and respiratory-related mortality (hazard ratios, 0.76 and 0.70, respectively) than those in the very-low category over the mean follow-up of 12 years. The authors concluded that there was a link between steps, and accelerometers, which detect acceleration. The increasing interest in motion detectors reflects the recognized limitations of self-reported instruments measures in quantifying PA.
Pedometers estimate the number of steps an individuals takes and, indirectly, can be used to provide an estimate of active energy expenditure. Steps per day, unlike most other PA parameters, are intuitive, being grounded in everyday experience. Additionally, this allows clinicians to provide feedback information on steps that can be used to motivate individuals to walk more. [23] [24] [25] However, a pedometer assessment of activity has limitations. Pedometer devices worn on the waist are relatively insensitive to movements of the upper extremity, and thereby miss some potentially important activity information. Additionally, they may not be sensitive enough to detect walking activity in slow-moving individuals, which is often the case with COPD patients. For example, a study by Dallas et al, 26 using pedometers in COPD to detect changes in PA after pulmonary rehabilitation, failed to show any significant effects-a negative finding that was blamed on the insensitivity of the devices.
For the purpose of activity measurement in humans, accelerometers are electronic devices worn on the body that detect acceleration. Being more sophisticated (and more expensive) than pedometers, they are more sensitive to movements in inactive or slowly-moving individuals and, theoretically, would be more suitable to assessing PA in patients with COPD. They are better at detecting motions over a wider range of activities, and can be even responsive to detecting movements in the upper extremities, although the clinical relevance of the latter measurement is not clear. Acceleration can be measured in 1, 2, or 3 planes, (uniaxial, biaxial or triaxial accelerometers, respectively). Practically, they are, at times, too sensitive in detecting movements. For instance, they can demonstrate considerable physical "activity" in someone driving an automobile on a bumpy road.
The analysis of accelerometer output can be extrapolated to provide a variety of activity outcomes, such as summed movements in 3 planes per minute (vector magnitude units); estimated steps per day; estimated energy expenditure; and time spent above or below an activity threshold. The threshold cut-off can be used to estimate time spent in sedentary behavior (which, in general, may independently predict poor outcome) 27 or time spent above a moderate intensity threshold. 28 Estimating time above an activity intensity threshold can eliminate "noise" from minor motions detected by the ultra-sensitive devices. Some devices also have positioning systems that can determine time spent in supine or upright activities, the latter including walking activity.
5 Unfortunately, the differing designs of the accelerometer devices make it difficult to compare their output. 43 The findings of decreased activity early in the course of COPD suggest that maladaptive behavior, not just symptom-limitation, also plays a role in inactivity in these patients.
Factors associated with physical activity in patients with chronic obstructive pulmonary disease PA in all individuals is a complex phenomenon that is undoubtedly influenced by multiple factors. 9 Some variables, such as extreme weather, probably affect PA in the COPD patient in similar ways to the healthy individual. Other influential factors are perhaps unique to patients with chronic disease in general. Others are releated to COPD patients in particular. The following will discuss some of the latter activity-modifying variables.
Airway obstruction
In general, FEV 1 shows only a weak-to-moderate relationship with PA in COPD, 9 underscoring the importance of other factors in determining this variable. The association between dynamic hyperinflation (increases in end-expiratory lung volumes with exercise or increased respiratory rate-an important factor in exertional dyspnea in COPD) and PA is somewhat stronger. 44 In a study by Garcia-Rio et al, 44 directly measured PA (vector magnitude units from a triaxial accelerometer worn on the waist) was lower in those 89 study patients with demonstrated dynamic hyperinflation than in those 21 patients who did not hyperinflate. This factor, along with the 6-minute walking distance (see below), remained in a multivariate model predicting PA. Since the associations between these physiological variables and PA are not particularly robust, other factors influencing activity must also be important.
Exercise endurance capacity Higher exercise capacity may be considered permissive of higher PA intensity and duration in the COPD patient: those stopping exercise in the laboratory at low levels because of dyspnea or leg fatigue (or both) cannot be expected to be very physically active outside of this setting. Thus, it should be no surprise that exercise performance does relate to a directly measured PA level. For example, performance on tests of lower limb muscle function or field tests of exercise capacity (such as the 6-minute walk test or the shuttle walk test) significantly predicts PA level in COPD, usually more strongly than lung function tests.
45-48
Pulmonary physiological abnormality and exercise capacity limitation appear to independently predict low PA. For example, in the above study by Garcia-Rio et al, 44 in their multivariate linear regression analysis, dynamic hyperinflation and 6-minute walking distance both remained in their model, predicting 84% of the variance in PA.
inactivity and this adverse outcome in COPD. Indeed, not only do low baseline levels of PA predict mortality, but decline in PA over years also predicts outcome. In a re-analysis of the Copenhagen City data, Vaes et al 34 demonstrated that a decline from higher to low PA at follow-up was associated with an increased mortality risk in subjects with and without COPD. The authors concluded that this suggests that PA should be encouraged in the earliest stages of COPD in order to maintain a PA level that is as high as possible, and thus effect a better long-term prognosis.
Health care utilization Lower PA is associated with a higher risk of hospitalization in COPD. In the above-cited study by Garcia-Aymerich, 33 those with very low baseline self-reported PA had a higher rate of subsequent hospitalization for COPD by approximately 25% over the follow-up period than those with higher activity levels. Additionally, decline in PA over time predicts this increased health care utilization (as well as mortality, even after adjustment for relevant potential confounders, including age, forced expiratory volume in 1 second (FEV 1 ), and prior hospitalizations.
35
Progression of chronic obstructive pulmonary disease There is some evidence that physical inactivity in COPD patients is associated with a higher decline in lung function than in those who are more active. For example, a study of a population-based sample in Copenhagen (n = 6790, recruitment from 1981-1983, follow-up from 1991-1994) evaluated lung function in patients with COPD, defined as a ratio of FEV 1 to forced vital capacity (FEV 1 /FVC) of 70 or less. 36 In active smokers (but not nonsmokers), those with moderate to high PA levels had a lower risk of developing COPD than those with low levels: odds ratio, 0.77, P = 0.027. Additionally, those COPD patients with moderate or high PA had a lower rate of decline in FEV 1 and FVC than those with low PA, even after adjusting for potential confounder variables: a decline in FEV 1 of 2.6 vs 4.8 ml/y and a decline in FVC of 2.6 vs 7.7 ml/y for moderate-high and low activity categories, respectively, P for trend 0.0001. The cause or causes of the different rates of decline in lung function decline remain to be elucidated, particularly since mechanistic reasons are difficult to conceptualize.
Physical inactivity in patients with chronic obstructive pulmonary disease On average, patients with COPD are more inactive when compared with agematched healthy individuals and the majority do not meet clinical guidelines for daily PA.
5,6,37-42 To illustrate this, a study by Pitta et al 5 demonstrated that COPD patients spent less time walking and standing and more time lying than healthy people of approximately the same age. Furthermore, these COPD patients were less likely to walk 30 minutes per day, and their movement intensity was lower. Of considerable interest, a this association, changes in leisure time PA are associated with corresponding changes in health status: for example, COPD patients with increases in PA over time had increases in health status scores, and vice versa. 62 The obvious question deriving from these associations is: what is the horse and what is the cart? In other words, does physical inactivity drive poor health status, does poor health status drive physical inactivity, or is the causality bidirectional?
Increasing physical activity in patients with chronic obstructive pulmonary disease Bronchodilators Compared to the extensive literature on the beneficial effect of bronchodilators in COPD on airway obstruction, hyperinflation, dyspnea, exercise capacity, and health status, their effect on increasing PA has received little attention. One randomized crossover trial comparing the long--acting β-agonist bronchodilator, indacaterol, to placebo showed no effect on directly-measured activity despite demonstrable improvements in exercise capacity. 63 However, a second, 3-arm, crossover study testing this drug that compared its effect on activity to that of placebo and the long--acting anticholinergic bronchodilator, tiotropium, showed a significant positive effect of the β-agonist on activity. 64 A large study comparing tiotropium to placebo showed a nonsignificant, numerical increase in activity. 65 Finally, a crossover trial of the long-acting anticholinergic bronchodilator, aclidinium, to placebo demonstrated a small increase in one (of several) activity parameters. 66 These studies suggest that simply increasing lung function will have only a marginal effect on PA. Bronchodilators alone are not a panacea when it comes to PA.
Supplemental oxygen therapy Regular use of supplemental oxygen prolongs life in hypoxemic patients with COPD. However, the beneficial effect of oxygen therapy on other outcomes of importance to patients has not been well tested. One very small, randomized study evaluated the effect of adding ambulatory oxygen (as opposed to a stationary system only) on hypoxemic COPD patients receiving continuous oxygen therapy. 67 The study did not show a beneficial effect of adding supplemental oxygen on activity. Larger studies are needed to better examine this relationship.
Pulmonary rehabilitation With its essential components of exercise training and self-management education, and its proven benefits in exercise capacity, comprehensive pulmonary rehabilitation would be expected to have a positive effect on PA in patients with COPD. Despite this strong rationale, randomized clinical trials testing this outcome 41, 42, [68] [69] [70] [71] [72] [73] [74] [75] have thus far provided inconsistent results. Somewhat less than one --half of these trials demonstrated increases in PA despite often significant improvements in other outcome areas. Putative reasons for the negative result have included small, underpowered Chronic obstructive pulmonary disease: exacerbations The exacerbation of COPD can be defined as "… a sustained worsening of the patient's condition, from the stable state and beyond normal day-to-day variations that is acute in onset and may warrant additional treatment in a patient with underlying COPD." 49 Exacerbations cause a substantial increase in symptoms and a decrease in health status lasting for weeks after onset. 50 Therefore, PA would be expected to decrease in this setting as well. One longitudinal study addressed this issue by evaluating PA (with a triaxial accelerometer worn on the wrist) over about 6 consecutive months in a small number of patients with COPD.
51 Exacerbations (onset and termination) over this time period were defined using the 14-item Exacerbations of Chronic Pulmonary Disease Tool (EXACT) daily dairy. 52 Patients spent fewer minutes per day in higher level PA during exacerbation days than non-exacerbation days, with the greatest reduction occurring in the first week. Following the termination of the exacerbation, activity remained low for approximately more 2 weeks.
Comorbid conditions COPD patients frequently have clinically-significant comorbid conditions; these almost certainly add to the physical inactivity problem in this disease. Comorbid states that have been demonstrated to be associated with decreased PA in COPD patients include quadricep dysfunction from deconditioning, systemic inflammation, metabolic syndrome, and left heart dysfunction.
53,54 Undoubtedly more exist. The relationship between PA and anxiety and depression has been inconsistent, with most studies failing to demonstrate significant associations. In one study, anxiety and depression had opposite effects: higher anxiety levels were associated with lower PA, while higher depression scores were associated with higher PA.
55
Chronic obstructive pulmonary disease: symptoms and health status Symptoms common to COPD, dyspnea, and fatigue are associated with lower PA levels in patients.
6,48,56 However, the relationship between symptoms and activity is probably complex. For example, a longitudinal study by Lareau et al 57 in a small number of COPD patients did not show changes in exertional dyspnea over the years of follow-up despite progressive declines in the FEV 1 . However, self-reported physical activities also declined over this interval, suggesting that if patients ratchet down their PA, exertional dyspnea will not increase.
Impaired health status also mirrors physical inactivity, but the correlation is only weak to moderate.
48,58-61 Finally, a longitudinal decline in PA is associated with a corresponding decline health status in COPD. 62 In one study of 346 patients with COPD, very low questionnaire-rated PA (the equivalent of walking less than 15 minutes per day) was associated with worse health status, as measured by a generic instrument.
59 Adding to outcome, including increased health care utilization, increased mortality risk, and (perhaps) an accelerated decline in cigarette smokers with COPD. Efforts to increase PA in patients with COPD have been challenging, and there appears to be no "quick-fix" to this problem. Increased efforts to better understand the determinants of PA as well as effective strategies to improve this variable must be undertaken if we are to improve the lives of our patients. Future research must include both advancing the science and treating the patient. trials, poor sensitivity of pedometers to detect steps in slow-moving COPD patients, and unfavorable signal-to-noise characteristics of some sensitive accelerometers. It may be that the behavioral program in traditional pulmonary rehabilitation must be modified to focus on this important outcome. For example, many pulmonary rehabilitation programs are of relatively short duration, (typically 8-12 weeks), which may not provide enough time to elicit behavior change. To illustrate this potential limitation, one randomized trial of pulmonary rehabilitation 75 demonstrated that, unlike exercise capacity and health status (which improved by 3 months), PA took 6 months to significantly increase. This led to the editorial remark that it takes 3 months to train the muscles and 6 months to train the brain! 76
Physical activity counseling As mentioned earlier, physical inactivity in COPD may be as much the result of maladaptive behavior patterns as symptom-limitation of exercise capacity. This conclusion is based on relatively weak-to-moderate correlations between exercise capacity and PA in cross-sectional studies already discussed. Consequently, a variety of cognitive and behavioral interventions have been offered to increase PA in healthy children and adults. Unfortunately, for patients with COPD, many of these interventions have not been proved successful.
One promising intervention is feedback information from wearable activity monitors, which has been successfully used to increase daily PA in various populations, 77 including a small (negative) study in COPD. 24 One recent trial of pedometer feedback in COPD patients deserves special comment. 25 Ninety-seven patients were randomized to either PA encouragement alone or a pedometer-based feedback program. Outcome variables included mean step count over 1 week, the 6-minute walk distance, dyspnea, and health status. The pedometer feedback group showed significantly greater improvements in step counts per day, walk distance, and health status, leading the investigators to conclude that this form of intervention may increase PA and quality of life.
Summary and future directions This summary of the European Respiratory Society statement on PA discusses the concepts of PA and exercise which, while interrelated, are not synonymous. Exercise capacity is permissive of PA. However, PA is undoubtedly influenced my multiple factors. Methods by which PA can be measured, their limitations, and potential applications has also been reviewed. COPD patients are generally quite inactive and that this physical inactivity is associated with impairment in other areas, including lung function (airway obstruction and dynamic hyperinflation) exercise capacity, and health status, as well as the presence of certain comorbid conditions. As would be anticipated, PA is reduced during the COPD exacerbation. Importantly, physical inactivity is associated with adverse
